Phase II study of modified docetaxel, cisplatin and S-1 (mDCS) combination chemotherapy in patients with unresectable metastatic gastric cancer

被引：0
|
作者：
Sato, Y. [1 ]
Ohnuma, H. [2 ]
Okamoto, K. [3 ]
Miyamoto, H. [3 ]
Hirakawa, M. [2 ]
Uemura, N. [4 ]
Kikuchi, S. [2 ]
Sagawa, T. [4 ]
Fujikawa, K. [4 ]
Takahashi, Y. [4 ]
Minami, S. [5 ]
Okuda, T. [5 ]
Takahashi, M. [6 ]
Kato, J. [2 ]
Takayama, T. [3 ]
机构：
[1] Tokushima Univ, Grad Sch Biomed Sci, Dept Community Med Gastroenterol & Oncol, Tokushima, Japan
[2] Sapporo Med Univ, Med Oncol & Hematol, Sapporo, Hokkaido, Japan
[3] Tokushima Univ, Grad Sch Biomed Sci, Dept Gastroenterol & Oncol, Tokushima, Japan
[4] Hokkaido Canc Ctr, Dept Gastroenterol, Sapporo, Hokkaido, Japan
[5] Oji Gen Hosp, Gastroenterol, Tomakomai, Japan
[6] Sapporo Kyoritsu Gorinbashi Hosp, Dept Gastroenterol, Sapporo, Hokkaido, Japan
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
680P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase II study of modified docetaxel, cisplatin, and S-1 (mDCS) chemotherapy for unresectable advanced gastric cancer
    Naoki Uemura
    Shohei Kikuchi
    Yasushi Sato
    Hiroyuki Ohnuma
    Koichi Okamoto
    Hiroshi Miyamoto
    Masahiro Hirakawa
    Tamotsu Sagawa
    Koshi Fujikawa
    Yasuo Takahashi
    Toshinori Okuda
    Shinya Minami
    Minoru Takahashi
    Tetsuro Okamoto
    Kohichi Takada
    Koji Miyanisi
    Tetsuji Takayama
    Junji Kato
    [J]. Cancer Chemotherapy and Pharmacology, 2017, 80 : 707 - 713
  • [2] A phase II study of modified docetaxel, cisplatin, and S-1 (mDCS) chemotherapy for unresectable advanced gastric cancer
    Uemura, Naoki
    Kikuchi, Shohei
    Sato, Yasushi
    Ohnuma, Hiroyuki
    Okamoto, Koichi
    Miyamoto, Hiroshi
    Hirakawa, Masahiro
    Sagawa, Tamotsu
    Fujikawa, Koshi
    Takahashi, Yasuo
    Okuda, Toshinori
    Minami, Shinya
    Takahashi, Minoru
    Okamoto, Tetsuro
    Takada, Kohichi
    Miyanisi, Koji
    Takayama, Tetsuji
    Kato, Junji
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (04) : 707 - 713
  • [3] Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer
    Sato, Y.
    Takayama, T.
    Sagawa, T.
    Tanaka, S.
    Takahashi, S.
    Takimoto, R.
    Kato, J.
    Ohnuma, H.
    Takahashi, Y.
    Niitsu, Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer
    Sato, Yasushi
    Takayama, Tetsuji
    Sagawa, Tamotsu
    Takahashi, Yasuo
    Ohnuma, Hiroyuki
    Okubo, Syunichi
    Shintani, Naoaki
    Tanaka, Shingo
    Kida, Masaya
    Sato, Yasuhiro
    Ohta, Hidetoshi
    Miyanishi, Koji
    Sato, Tsutomu
    Takimoto, Rishu
    Kobune, Masayoshi
    Yamaguchi, Koji
    Hirata, Koichi
    Niitsu, Yoshiro
    Kato, Junji
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (04) : 721 - 728
  • [5] Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer
    Yasushi Sato
    Tetsuji Takayama
    Tamotsu Sagawa
    Yasuo Takahashi
    Hiroyuki Ohnuma
    Syunichi Okubo
    Naoaki Shintani
    Shingo Tanaka
    Masaya Kida
    Yasuhiro Sato
    Hidetoshi Ohta
    Koji Miyanishi
    Tsutomu Sato
    Rishu Takimoto
    Masayoshi Kobune
    Koji Yamaguchi
    Koichi Hirata
    Yoshiro Niitsu
    Junji Kato
    [J]. Cancer Chemotherapy and Pharmacology, 2010, 66 : 721 - 728
  • [6] Phase I study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer
    T Takayama
    Y Sato
    T Sagawa
    T Okamoto
    H Nagashima
    Y Takahashi
    H Ohnuma
    G Kuroiwa
    K Miyanishi
    R Takimoto
    T Matsunaga
    J Kato
    K Yamaguchi
    K Hirata
    Y Niitsu
    [J]. British Journal of Cancer, 2007, 97 : 851 - 856
  • [7] Phase I study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer
    Takayama, T.
    Sato, Y.
    Sagawa, T.
    Okamoto, T.
    Nagashima, H.
    Takahashi, Y.
    Ohnuma, H.
    Kuroiwa, G.
    Miyanishi, K.
    Takimoto, R.
    Matsunaga, T.
    Kato, J.
    Yamaguchi, K.
    Hirata, K.
    Niitsu, Y.
    [J]. BRITISH JOURNAL OF CANCER, 2007, 97 (07) : 851 - 856
  • [8] PHASE II STUDY WITH DOCETAXEL, OXALIPLATIN AND S-1 COMBINATION CHEMOTHERAPY FOR PATIENTS WITH METASTATIC GASTRIC CANCER
    Zang, D. Y.
    Kang, Y.
    Ryoo, B.
    Ryu, M.
    Lee, S. S.
    Song, H. H.
    Jung, J. Y.
    Kwon, J. H.
    Kim, H. S.
    Choi, D. R.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 261 - 261
  • [9] Phase II study of a combination of S-1 and paclitaxel in patients with unresectable or metastatic gastric cancer
    Narahara, Hiroyuki
    Fujitani, Kazumasa
    Takiuchi, Hiroya
    Sugimoto, Naotoshi
    Inoue, Kentaro
    Uedo, Noriya
    Tsukuma, Hideaki
    Tsujinaka, Toshimasa
    Furukawa, Hiroshi
    Taguchi, Tetsuo
    [J]. ONCOLOGY, 2008, 74 (1-2) : 37 - 41
  • [10] Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic gastric cancer
    Park, Keon Woo
    Ahn, Jin Seok
    Park, Young Suk
    Lee, Jeeyun
    Kang, Jung Hoon
    Park, Joon Oh
    Lim, Ho Yeong
    Im, Young-Hyuck
    Kang, Won Ki
    Park, Keunchil
    Lee, Soon Il
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (01) : 17 - 21
12345